Clue Expands Wearable Tech Partnerships for Women's Health Insights
Clue Expands Wearable Tech for Women's Health

In a significant move for women's health technology, Clue has announced expanded integrations with multiple leading wearable device companies. This development promises to deliver more comprehensive health insights for millions of users worldwide.

New Partnerships Enhance Health Monitoring

Clue, the women-led period and cycle tracker trusted by over 100 million people globally, revealed on November 17, 2025 that it has established new partnerships with prominent wearable brands. The collaboration includes Withings, Ultrahuman, WHOOP, Huawei, Polar, Fitbit, Noise and Luna, building upon Clue's existing relationship with ŌURA that began in 2023.

These integrations will allow women and people with menstrual cycles to access a more complete picture of their health by combining wearable data with menstrual cycle information. The timing is particularly relevant as wearable devices and fitness trackers have seen massive adoption in recent years.

Strong Demand for Integrated Health Tracking

Recent data from Clue highlights the growing interest in connected health experiences. More than 60% of survey respondents reported they currently use or would consider using a wearable device primarily for monitoring their health or physical activity.

Additionally, nearly 40% expressed interest in tracking their menstrual cycle with wearable technology to better understand patterns and their body's changes. With over 80% of wearable users wearing their devices daily, and body temperature and sleep ranking among the most valued biometrics, Clue's new partnerships represent a natural evolution in personalized health technology.

How the Integrated System Works

The new functionality operates through a three-step process that seamlessly connects wearable data with menstrual health insights:

Continuous tracking: Wearable devices passively record skin temperature and sleep duration in the background throughout the day and night.

Smart synchronization: This biometric data is securely transferred and displayed within the Clue application, where it appears alongside self-tracked symptoms and cycle information.

Contextual insights: By combining wearable data with Clue's tracking capabilities, users can identify patterns that may relate to their menstrual cycle, perimenopause, or other life phases.

This integrated approach enables users to observe how sleep and temperature fluctuate during different cycle phases, helping them make correlations between temperature trends and ovulation, or between sleep patterns and energy levels or mood changes.

Exclusive Bundles and Member Benefits

To make these enhanced capabilities accessible to a broad audience, Clue and its partners are offering special bundles and discounts:

Withings: Temperature and sleep tracking integration, plus a Clue Plus x Withings bundle that includes an annual Clue Plus subscription with every ScanWatch 2 purchase.

Ultrahuman: Temperature and sleep duration tracking with 10% off Ultrahuman Ring for Clue Plus members, plus a bundled subscription offer.

WHOOP: Three months free Clue Plus via the Whoop app, plus discounts for Clue Plus subscribers.

Polar: Three months free Clue Plus with new Polar device purchases, plus device discounts for subscribers.

Fitbit: Temperature and sleep tracking with three months free Clue Plus for Fitbit Premium users in the US, Canada, UK, and Australia.

Luna: Clue Plus members receive 15% off all Luna devices, while all Luna users get three months free Clue Plus.

Rhiannon White, CEO of Clue, emphasized the importance of this expansion, stating that the company's mission centers on helping women and people with cycles understand their bodies and take control of their health. She noted that the growing appetite for cycle-aware wearables is driving Clue's growth as the most trusted platform for women's health data worldwide.

These new partnerships represent a significant step forward in creating connected health experiences that provide women with more choice and agency than ever before in managing their health and wellbeing.